Aiforia Technologies Plc, Press Release, March 6, 2024 at 09:00 a.m. EET ..read more

Why Ki-67? Although it is an important biomarker in oncology (mostly in breast and prostate), Ki-67 immunohistochemistry (IHC) analysis has yet to be standardized. Working groups have provided guidelines for Ki-67 scoring in different cancer types to limit pathologist’s variability.¹‚² AI solutions to assist scoring have recently emerged in the evaluation of Ki-67 as rapid and robust solutions. In this study, we compared the results of Ki-67 scoring performed with Aiforia® Platform (deep learning AI platform) against three independent pathologists on various solid tumors ..read more

Aiforia Technologies Plc, Press release, January 2, 2024 at 10.00 a.m. EET Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. The AI model was developed in collaboration with the Mayo Clinic. The AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for colorectal cancer treatment decisions.   ..read more

Dear customers, shareholders, and our team, As we stand at the threshold of a new year, I wanted to take a moment to review the events of 2023 and express my gratitude for your continued support and hard work that the team has done. It has been a year of important milestones for Aiforia as the first deployments of our clinical AI-solutions were kicked-off in key markets ..read more

Aiforia Technologies Plc, Press Release, October 20, 2023 at 10:00 a.m. EEST ..read more

Aiforia Technologies Plc, Press Release, 18 September 2023 at 09:00 a.m. EEST ..read more

Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m. EEST ..read more

Aiforia Technologies Plc  Inside information 29 June 2023 at 10:30 a.m. EEST ..read more

In cancer patients, the immune system's ability to recognize and destroy cancer cells is often suppressed due to several factors. Cancer cells can evade detection by the immune system by expressing unique or altered proteins on their surface, making it difficult for the body to identify them as foreign. Some cancer cells can produce substances that inhibit the activity of immune cells or activate regulatory T-cells, which suppress other immune cells. Chemotherapy and radiation therapy can also inhibit the immune system by killing cancer cells as well as healthy immune cells ..read more

Digital pathology refers to using digital imaging technology to acquire, manage, and analyze high-resolution digital images of pathological specimens, such as tissue samples or microscope slides. This process involves converting traditional glass slides into digital slides, which can be viewed, stored, and analyzed using computerized systems. Integrating digital pathology into educational settings allows students and educators to experience numerous benefits.  ..read more